Acyclovir Market, By Virus (Herpes Simplex Virus Type I (HSV-1), Herpes Simplex Virus Type II (HSV-2), Varicella Zoster Virus (VZV), Epstein - Barr virus (EBV), Cytomegalovirus (CMV)), By Application (HIV, Hepatitis, Herpes Simplex Virus, Influenza, Others), and Region - COVID-19 Impact Analysis and Forecast to 2026
Acyclovir Market, By Virus (Herpes Simplex Virus Type I (HSV-1), Herpes Simplex Virus Type II (HSV-2), Varicella Zoster Virus (VZV), Epstein - Barr virus (EBV), Cytomegalovirus (CMV)), By Application (HIV, Hepatitis, Herpes Simplex Virus, Influenza, Others), and Region...
Acyclovir is regarded as an antiviral medication, which finds usage in treating infections caused by the herpes simplex virus. There are also relatively few side effects caused by them such as diarrhea and nausea. It is primarily used for the treatment of diseases such as hepatitis, and chickenpox, among others. Acyclovir enables to reduce severity and pain & healing of sores or blisters in chicken pox. Also, it is widely used in the prevention of outbreak of genital herpes.
Covid-19 Impact Analysis
The outbreak of COVID-19 moderately affected the acyclovir industry. Due to diversion of medical field in treating COVID-19 patients, the funding to R&D activities related to viral diseases has been reduced, thus have faced a negligence which has caused a negative impact on the market growth.
Key Players
Key players operating in the global Acyclovir Market are-
Agio Pharmaceuticals Limited (India)
Synmedic Laboratories (India)
Zee Laboratories Ltd (India)
Cipla Inc. (India)
Bhavishya Pharmaceuticals Pvt Ltd
Geo Pharma Pvt Ltd (Georgia)
Finecure Pharmaceuticals Ltd (India)
Novus Life Sciences Pvt Ltd (India)
Talent Laboratories (India)
Adley Formulation (India)
Market Dynamics
The Acyclovir market is mainly driven by surge in geriatric population, rising population growth, introduction of nanotechnology to develop antiviral medication, growing prevalence of viral diseases, and technological developments in the innovation of antiviral medications. High prevalence of sexually transmitted diseases (STDs) is another key factor boosting the industry growth. Moreover, increasing need for broad spectrum drugs & application of antiviral in the pharmaceutical industry, further augments the market growth.
Segment’s Analysis
ApplicationTrends
Based on application, the acyclovir market has been classified into HIV, hepatitis, herpes simplex virus, influenza, and others. The HIV segment accounted for the largest market share in 2020, owing to its increasing number of HIV cases across the globe. Acyclovir can decrease HIV infections among HIV infected patients and has a reduced risk of mortality among patients treated with acyclovir, which further bolsters the segment growth.
Regional Trends
By region, the North America Acyclovir market accounted for a significant share of almost 44% in 2020 and is expected to grow at a robust CAGR during the review period. The Acyclovir market growth is mainly propelled by rising prevalence of viral diseases and prevalence of STDs the region. Moreover, presence of key product manufacturers, ongoing clinical trials, increasing healthcare expenditure, and well-equipped healthcare infrastructure further proliferates the market growth in the region.
The Asia Pacific Acyclovir market is expected to grow at a healthy CAGR during the review on account of growing awareness associated with viral cases and outbreaks. Moreover, rising incidence of HIV cases coupled with strong government policies supporting healthcare sector, further bolsters the regional market growth.
Critical Questions Answered in the Report
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global acyclovir market. The historic years considered for the study are 2016-2019, base year is 2020, estimated year is 2021, and forecast period is 2022-2026. Following are the critical questions answered in the report.
What are the key trends in the global acyclovir market?
How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in next five years?
What is the impact of COVID-19 on global acyclovir market?
What are the key strategies adopted by the major vendors to lead in the global acyclovir market?
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.
LOADING
LOADING
×
Please enter your contact details. It will allow our analysts to reach out to you.
The Acyclovir market is mainly driven by surge in geriatric population, rising population growth, introduction of nanotechnology to develop antiviral medication, growing prevalence of viral diseases, and technological developments in the innovation of antiviral medications.
North America Acyclovir market accounted for a significant share of almost 44% in 2020 and is expected to grow at a robust CAGR during the review period.